Latest News for: ose
Edit
Mowi ASA (OSE: MOWI): Quarterly dividend (Mowi ASA)
Public Technologies 11 Feb 2026
). 11 Feb 2026 06.30 CET. Subscribe. Issuer. Mowi ASA. The Board of Mowi ASA has resolved on 10 February 2026 to make a quarterly. distribution to shareholders of NOK 1.50 per share ... dividend up to and including 19 February 2026 ... February 2026 ... Source.
Edit
Mowi ASA (OSE:MOWI): Presentation of Q4 2025 results 11 February 2026 at 08:00 (CET)
Nasdaq Globe Newswire 02 Feb 2026
Mowi ASA hereby invites you to the presentation of the results for the fourth quarter 2025 at The Salmon, Strandpromenaden 11, 0252 Oslo, Norway ... .
Edit
OSE Immunotherapeutics Selects Chronic Pouchitis and Hidradenitis Suppurativa as New Key Indications for Lusvertikimab
Nasdaq Globe Newswire 29 Jan 2026
OSE Immunotherapeutics Selects Chronic Pouchitis and Hidradenitis Suppurativa as New Key Indications for Lusvertikimab ... .
Edit
Elvira Dyangani Ose Appointed Artistic Director of the Second Edition of Public Art Abu Dhabi Biennial
PR Newswire 22 Jan 2026
Elvira Dyangani Ose ... Elvira Dyangani Ose currently serves as Director of the MACBA, Museu d'Art Contemporani de Barcelona ... Dyangani Ose holds a degree in Art History from the Universitat Autònoma de Barcelona.
Edit
OSE Immunotherapeutics Welcomes FDA Orphan Drug Designation Granted to Pegrizeprument (VEL-101)
Nasdaq Globe Newswire 21 Jan 2026
OSE Immunotherapeutics Welcomes FDA Orphan Drug Designation Granted to Pegrizeprument (VEL-101) ... .
Edit
OSE Immunotherapeutics Welcomes FDA Orphan Drug Designation Granted to Pegrizeprument (VEL-101) (OSE Immunotherapeutics SA)
Public Technologies 21 Jan 2026
) OSE Immunotherapeutics Welcomes FDA Orphan Drug Designation Granted to Pegrizeprument (VEL-101). Nantes, France, January 21, 2026 - 6pm CET - OSE Immunotherapeutics SA (ISIN ... from OSE Immunotherapeutics in April 2021 ... ABOUT OSE IMMUNOTHERAPEUTICS.
Edit
21/01/2026 OSE Immunotherapeutics Welcomes FDA Orphan Drug Designation Granted to Pegrizeprument (VEL-101) (OSE Immunotherapeutics SA)
Public Technologies 21 Jan 2026
) OSE Immunotherapeutics Welcomes FDA Orphan Drug Designation Granted to Pegrizeprument (VEL-101). Nantes, France, January 21, 2026 - 6pm CET - OSE Immunotherapeutics SA (ISIN ... from OSE Immunotherapeutics in April 2021 ... ABOUT OSE IMMUNOTHERAPEUTICS.
Edit
The Daily Item
20 Jan 2026
Ose Okokie, Cedric Taylor III lead Howard to 78-69 victory over D-II's Morehouse
The Daily Item
20 Jan 2026
Ose Okokie had 21 points and Cedric Taylor III posted a double-double to lead Howard to a 78-69 victory over Division II's Morehouse ....
Edit
Restoring a Neoclassical Gem: The Revival of the Athens-Peloponnese Railway Station
Greek Reporter 20 Jan 2026
An architectural design for the revamped Athens-Peloponnese Railway Station. Credit. GAIAOSE. A major restoration project is underway to breathe new life into one of Athens’ most iconic landmarks. the Athens-Peloponnese Railway Station ... Credit. GAIAOSE.
Edit
MPC OSE Offshore, managed by MPC Capital, Secures Long-Term Financing for Newbuild Program (MPC Münchmeyer Petersen Capital AG)
Public Technologies 15 Jan 2026
The MPC OSE Offshore platform is backed by Eurazeo as lead investor ... "We are pleased to support MPC Capital and MPC OSE Offshore with this financing" said Guido Mülder, Board Member at Ostfriesische Volksbank.
Edit
Test Research, Inc. receives Outstanding Supplier Award from OSE (TRI - Test Research Inc)
Public Technologies 06 Jan 2026
... announce that it has been honored with the "Outstanding Supplier Award" by Orient Semiconductor Electronics (OSE) (TWSE.
Edit
The Daily Journal - San Mateo
17 Dec 2025
Ose Okojie posts double-double to help Howard fend off Drexel 74-66
The Daily Journal - San Mateo
17 Dec 2025
PHILADELPHIA (AP) — Ose Okojie totaled 17 points and 10 rebounds to help Howard fend off Drexel 74-66 on Tuesday ... .
- 1
- 2
- Next page »
